The alliance of sphingosine-1-phosphate and its receptors in immunity (original) (raw)
Hannun, Y. A. & Obeid, L. M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Rev. Mol. Cell. Biol.9, 139–150 (2008). This is a comprehensive overview of the cellular regulation and function of sphingolipid metabolism. ArticleCAS Google Scholar
Rivera, J. & Olivera, A. Src family kinases and lipid mediators in control of allergic inflammation. Immunol. Rev.217, 255–268 (2007). ArticleCASPubMed Google Scholar
Sanchez, T. & Hla, T. Structural and functional characteristics of S1P receptors. J. Cell. Biochem.92, 913–922 (2004). ArticleCASPubMed Google Scholar
Brinkmann, V. et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem.277, 21453–21457 (2002). ArticleCASPubMed Google Scholar
Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature427, 355–360 (2004). ArticleCASPubMed Google Scholar
Kunisawa, J. et al. Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFκB-inducing kinase in stromal cells. Blood111, 4646–4652 (2008). ArticleCASPubMed Google Scholar
Graler, M. H. & Goetzl, E. J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J.18, 551–553 (2004). ArticleCASPubMed Google Scholar
Mechtcheriakova, D. et al. Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal.19, 748–760 (2007). ArticleCASPubMed Google Scholar
Peest, U. et al. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake. J. Cell. Biochem.104, 756–772 (2008). ArticleCASPubMed Google Scholar
Zhao, Y. et al. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J. Biol. Chem.282, 14165–14177 (2007). ArticleCASPubMed Google Scholar
Pappu, R. et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science316, 295–298 (2007). ArticleCASPubMed Google Scholar
Schwab, S. R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science309, 1735–1739 (2005). ArticleCASPubMed Google Scholar
Yatomi, Y. Plasma sphingosine 1-phosphate metabolism and analysis. Biochim. Biophys. Acta1780, 606–611 (2008). ArticleCASPubMed Google Scholar
Venkataraman, K. et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ. Res.102, 669–676 (2008). This study indicates that endothelial cells can be a source of S1P in plasma. ArticleCASPubMedPubMed Central Google Scholar
Olivera, A. et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity26, 287–297 (2007). This paper shows that deficiency of SPHK2 in mast cells impairs antigen-induced calcium influx and PKC activation, and results in a broad defect in mast-cell effector functions. It also reveals a previously unrecognized role for circulating S1P in mast-cell responsiveness. ArticleCASPubMed Google Scholar
Mizugishi, K. et al. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol.25, 11113–11121 (2005). ArticleCASPubMedPubMed Central Google Scholar
Boujaoude, L. C. et al. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J. Biol. Chem.276, 35258–35264 (2001). ArticleCASPubMed Google Scholar
Kobayashi, N. et al. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J. Lipid Res.47, 614–621 (2006). ArticleCASPubMed Google Scholar
Mitra, P. et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl Acad. Sci. USA103, 16394–16399 (2006). This report identifies, for the first time in an immune cell, an ABC1 transporter as a transporter of S1P from mast cells. ArticleCASPubMedPubMed Central Google Scholar
Anada, Y., Igarashi, Y. & Kihara, A. The immunomodulator FTY720 is phosphorylated and released from platelets. Eur. J. Pharmacol.568, 106–111 (2007). ArticleCASPubMed Google Scholar
Hanel, P., Andreani, P. & Graler, M. H. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J.21, 1202–1209 (2007). ArticlePubMedCAS Google Scholar
Hla, T. & Maciag, T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem.265, 9308–9313 (1990). CASPubMed Google Scholar
Spiegel, S. Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein- coupled receptors. Ann. N. Y. Acad. Sci.905, 54–60 (2000). ArticleCASPubMed Google Scholar
Walzer, T. et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nature Immunol.8, 1337–1344 (2007). This paper shows the participation of S1PR5 in the trafficking of NK cells. ArticleCAS Google Scholar
Czeloth, N. et al. Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen. J. Immunol.179, 5855–5863 (2007). ArticleCASPubMed Google Scholar
Dorsam, G. et al. Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J. Immunol.171, 3500–3507 (2003). ArticleCASPubMed Google Scholar
Jolly, P. S. et al. Transactivation of sphingosine-1-phosphate receptors by FcɛRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med.199, 959–970 (2004). ArticleCASPubMedPubMed Central Google Scholar
Yokoo, E. et al. Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1P2: cross-talk between platelets and mast cells. J. Biochem.135, 673–681 (2004). ArticleCASPubMed Google Scholar
Okamoto, H. et al. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol. Cell. Biol.20, 9247–9261 (2000). ArticleCASPubMedPubMed Central Google Scholar
Sugimoto, N., Takuwa, N., Okamoto, H., Sakurada, S. & Takuwa, Y. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol. Cell. Biol.23, 1534–1545 (2003). ArticleCASPubMedPubMed Central Google Scholar
Halin, C. et al. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. Blood106, 1314–1322 (2005). ArticleCASPubMedPubMed Central Google Scholar
Yopp, A. C. et al. FTY720-enhanced T cell homing is dependent on CCR2, CCR5, CCR7, and CXCR4: evidence for distinct chemokine compartments. J. Immunol.173, 855–865 (2004). ArticleCASPubMed Google Scholar
Schwab, S. R. & Cyster, J. G. Finding a way out: lymphocyte egress from lymphoid organs. Nature Immunol.8, 1295–1301 (2007). ArticleCAS Google Scholar
Allende, M. L., Dreier, J. L., Mandala, S. & Proia, R. L. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem.279, 15396–15401 (2004). This study, together with references 5 and 11, shows that lymphocyte egress into the blood depends on a gradient of S1P from tissue (low concentration) to blood (high concentration) and on lymphocyte S1PR1. It also shows that plasma S1P is mostly generated by erythrocytes. ArticleCASPubMed Google Scholar
Allende, M. L. et al. S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues. FASEB J.22, 307–315 (2008). ArticleCASPubMed Google Scholar
Kabashima, K. et al. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med.203, 2683–2690 (2006). ArticleCASPubMedPubMed Central Google Scholar
Gohda, M. et al. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer's patches for intestinal IgA responses. J. Immunol.180, 5335–5343 (2008). ArticleCASPubMed Google Scholar
Kurashima, Y. et al. Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy. J. Immunol.179, 1577–1585 (2007). ArticleCASPubMed Google Scholar
Cinamon, G. et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nature Immunol.5, 713–720 (2004). ArticleCAS Google Scholar
Cinamon, G., Zachariah, M. A., Lam, O. M., Foss, F. W. Jr & Cyster, J. G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nature Immunol.9, 54–62 (2008). ArticleCAS Google Scholar
Ledgerwood, L. G. et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nature Immunol.9, 42–53 (2008). ArticleCAS Google Scholar
Massberg, S. et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell131, 994–1008 (2007). This study shows that S1PR1 functions in the trafficking of HSPCs through non-lymphoid tissues, which has a role in immunosurveillance. ArticleCASPubMedPubMed Central Google Scholar
Bai, A., Hu, H., Yeung, M. & Chen, J. Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J. Immunol.178, 7632–7639 (2007). ArticleCASPubMed Google Scholar
Carlson, C. M. et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature442, 299–302 (2006). ArticleCASPubMed Google Scholar
Sebzda, E., Zou, Z., Lee, J. S., Wang, T. & Kahn, M. L. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nature Immunol.9, 292–300 (2008). ArticleCAS Google Scholar
Gonzalez-Cabrera, P. J., Hla, T. & Rosen, H. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics. J. Biol. Chem.282, 7254–7264 (2007). ArticleCASPubMed Google Scholar
Oo, M. L. et al. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J. Biol. Chem.282, 9082–9089 (2007). ArticleCASPubMed Google Scholar
Pham, T. H., Okada, T., Matloubian, M., Lo, C. G. & Cyster, J. G. S1P1 receptor signaling overrides retention mediated by G α i-coupled receptors to promote T cell egress. Immunity28, 122–133 (2008). ArticleCASPubMed Google Scholar
Alfonso, C., McHeyzer-Williams, M. G. & Rosen, H. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors. Eur. J. Immunol.36, 149–159 (2006). ArticleCASPubMed Google Scholar
Shiow, L. R. et al. CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature440, 540–544 (2006). ArticleCASPubMed Google Scholar
Rosen, H., Sanna, M. G., Cahalan, S. M. & Gonzalez-Cabrera, P. J. Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends Immunol.28, 102–107 (2007). ArticleCASPubMed Google Scholar
Lo, C. G., Xu, Y., Proia, R. L. & Cyster, J. G. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med.201, 291–301 (2005). ArticleCASPubMedPubMed Central Google Scholar
Sanna, M. G. et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nature Chem. Biol.2, 434–441 (2006). ArticleCAS Google Scholar
Wei, S. H. et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nature Immunol.6, 1228–1235 (2005). ArticleCAS Google Scholar
Foss, F. W. Jr et al. Synthesis and biological evaluation of γ-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg. Med. Chem.15, 663–677 (2007). ArticleCASPubMed Google Scholar
Liu, Y. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest.106, 951–961 (2000). ArticleCASPubMedPubMed Central Google Scholar
Allende, M. L., Yamashita, T. & Proia, R. L. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood102, 3665–3677 (2003). ArticleCASPubMed Google Scholar
Singer, I. I. et al. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J. Immunol.175, 7151–7161 (2005). ArticleCASPubMed Google Scholar
Sanchez, T. et al. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem.278, 47281–47290 (2003). ArticleCASPubMed Google Scholar
Idzko, M. et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J. Clin. Invest.116, 2935–2944 (2006). ArticleCASPubMedPubMed Central Google Scholar
Maeda, Y. et al. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. J. Immunol.178, 3437–3446 (2007). ArticleCASPubMed Google Scholar
Lan, Y. Y. et al. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am. J. Transplant.5, 2649–2659 (2005). ArticleCASPubMed Google Scholar
Idzko, M. et al. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J.16, 625–627 (2002). ArticleCASPubMed Google Scholar
Muller, H. et al. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur. J. Immunol.35, 533–545 (2005). ArticlePubMedCAS Google Scholar
Niessen, F. et al. Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation. Nature452, 654–658 (2008). This paper describes a new role for DCs in the dissemination of inflammation and coagulation during severe sepsis, and reveals the involvement of SPHK1 and S1PR3 activation by PAR1 in this process. ArticleCASPubMed Google Scholar
Riewald, M. & Ruf, W. Science review: role of coagulation protease cascades in sepsis. Crit. Care7, 123–129 (2003). ArticlePubMed Google Scholar
Kaneider, N. C. et al. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nature Immunol.8, 1303–1312 (2007). ArticleCAS Google Scholar
Choi, O., H., Kim, J.-H. & Kinet, J.-P. Calcium mobilization via sphingosine kinase in signalling by the FcɛRI antigen receptor. Nature380, 634–636 (1996). ArticleCASPubMed Google Scholar
Melendez, A. J. & Khaw, A. K. Dichotomy of Ca2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J. Biol. Chem.277, 17255–17262 (2002). ArticleCASPubMed Google Scholar
Olivera, A. et al. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem.281, 2515–2525 (2006). ArticleCASPubMed Google Scholar
Prieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. E. & Baumruker, T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after FcɛRI triggering. J. Exp. Med.190, 1–8 (1999). ArticleCASPubMedPubMed Central Google Scholar
Olivera, A. & Rivera, J. Sphingolipids and the balancing of immune cell function: lessons from the mast cell. J. Immunol.174, 1153–1158 (2005). ArticleCASPubMed Google Scholar
Fueller, M., Wang, D. A., Tigyi, G. & Siess, W. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate. Cell Signal.15, 367–375 (2003). ArticleCASPubMed Google Scholar
Jiang, L. I. et al. Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J. Biol. Chem.282, 10576–10584 (2007). ArticleCASPubMed Google Scholar
Nofer, J. R. et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation115, 501–508 (2007). ArticleCASPubMed Google Scholar
Dueñas, A. I. et al. Selective attenuation of Toll-like receptor 2 signaling may explain the atheroprotective effect of sphingosine 1-phosphate. Cardiovasc. Res.79, 537–544 (2008). ArticlePubMedCAS Google Scholar
Weigert, A. et al. Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood108, 1635–1642 (2006). ArticleCASPubMed Google Scholar
Gude, D. R. et al. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal. FASEB J., 22, 2629–2638 (2008). ArticleCASPubMedPubMed Central Google Scholar
Rosen, H. & Goetzl, E. J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nature Rev. Immunol.5, 560–570 (2005). ArticleCAS Google Scholar
Jin, Y. et al. Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood101, 4909–4915 (2003). ArticleCASPubMed Google Scholar
Graler, M. H., Huang, M. C., Watson, S. & Goetzl, E. J. Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes. J. Immunol.174, 1997–2003 (2005). ArticlePubMed Google Scholar
Song, J. et al. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice. J. Pharmacol. Exp. Ther.324, 276–283 (2008). ArticleCASPubMed Google Scholar
Huang, M. C., Watson, S. R., Liao, J. J. & Goetzl, E. J. Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. J. Immunol.178, 6806–6813 (2007). ArticleCASPubMed Google Scholar
Wang, W., Huang, M. C. & Goetzl, E. J. Type 1 sphingosine 1-phosphate G protein-coupled receptor (S1P1) mediation of enhanced IL-4 generation by CD4 T cells from S1P1 transgenic mice. J. Immunol.178, 4885–4890 (2007). ArticleCASPubMed Google Scholar
Wang, W., Graeler, M. H. & Goetzl, E. J. Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J.19, 1731–1733 (2005). ArticleCASPubMed Google Scholar
Sekiguchi, M. et al. Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome. J. Immunol.180, 1921–1928 (2008). ArticleCASPubMed Google Scholar
Liao, J. J., Huang, M. C. & Goetzl, E. J. Cutting Edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate. J. Immunol.178, 5425–5428 (2007). This study, together with reference 86, shows that S1P–S1PR1 activation can provide an alternative pathway to IL-23 stimulation for the differentiation of CD4+ T cells into IL-17-producing cells. ArticleCASPubMed Google Scholar
Jacobson, J. R. & Garcia, J. G. Novel therapies for microvascular permeability in sepsis. Curr. Drug Targets.8, 509–514 (2007). ArticleCASPubMed Google Scholar
Deutschman, D. H. et al. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am. Heart J.146, 62–68 (2003). ArticleCASPubMed Google Scholar
Ammit, A. J. et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J.15, 1212–1214 (2001). ArticleCASPubMed Google Scholar
Kitano, M. et al. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum.54, 742–753 (2006). ArticleCASPubMed Google Scholar
Yamashita, Y. et al. Cutting Edge: genetic variation influences FcɛRI-induced mast cell activation and allergic responses. J. Immunol.179, 740–743 (2007). ArticleCASPubMed Google Scholar
Rivera, J. & Tessarollo, L. Genetic background and the dilema of translating mouse studies to humans. Immunity28, 1–4 (2008). ArticleCASPubMed Google Scholar
Maki, T., Gottschalk, R., Ogawa, N. & Monaco, A. P. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720. Transplantation79, 1051–1055 (2005). ArticleCASPubMed Google Scholar
Srinivasan, S. et al. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. Diabetes57, 484–493 (2008). ArticleCASPubMed Google Scholar
Marino, E. et al. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes57, 395–404 (2008). ArticleCASPubMed Google Scholar
Kappos, L. et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med.355, 1124–1140 (2006). ArticleCASPubMed Google Scholar
Foster, C. A. et al. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol. 6 June 2008 (doi: 0.1111/j.1750-3639.2008.0018).
Aranami, T. & Yamamura, T. Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int.57, 115–120 (2008). ArticleCASPubMed Google Scholar
Roviezzo, F. et al. Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate. Proc. Natl Acad. Sci. USA101, 11170–11175 (2004). ArticleCASPubMedPubMed Central Google Scholar
Matsuyuki, H. et al. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. Cell. Mol. Immunol.3, 429–437 (2006). CASPubMed Google Scholar